Medical Condition News

RSS

Personalized clotting profiles could benefit people at risk from strokes and heart attacks

People at risk from strokes and heart attacks could benefit from personalized clotting profiles to help clinicians prescribe more precise treatments, thanks to new research.

20 Oct 2021

Discovery could lead to new treatments for axial spondyloarthritis

In a paper published today in the journal Science Translational Medicine, researchers at the Schroeder Arthritis Institute, part of University Health Network in Toronto, have made a discovery that could lead to new treatments for axial spondyloarthritis (SpA), a painful and debilitating form of arthritis which affects 1-2% of Canadians and causes inflammation in the spine, joints, eyes, gut and skin.

20 Oct 2021

Albert Einstein College of Medicine wins new NIH funding to support diabetes research

Albert Einstein College of Medicine has received a five-year, $4 million grant from the National Institutes of Health to support the New York Regional Center for Diabetes Translation Research (NY-CDTR).

20 Oct 2021

Discovery could help develop a new treatment strategy for patients with melanoma

A new study led by Yale Cancer Center researchers shows that the enzyme KDM5B suppresses anti-melanoma immunity.

20 Oct 2021

Study investigates whether continued magnetic seizure therapy can prevent relapse of depression

Treatment-resistant depression or TRD is exactly what it sounds like: a form of mental illness that defies effective therapy. It is not rare, with an estimated 3 million persons in the United States suffering from TRD.

20 Oct 2021

Underexpression of specific metabolic enzyme is a common feature in kidney cancer, study shows

A team of investigators has discovered that the underexpression of a specific metabolic enzyme is a common and adverse epigenetic modulating feature in clear cell renal cell carcinoma (ccRCC), according to a recent study published in Proceedings of the National Academy of Sciences.

20 Oct 2021

U-M study receives $13 million grant to track cancer risk from environmental exposures

Heavy metals like lead, industrial pollution from steel mills, coal-fired power plants or oil refineries, “forever chemicals” called PFAS that don’t break down in the environment—how much are Michigan residents exposed to these environmental contaminants and what does this mean for their risk of developing cancer?

20 Oct 2021

Research may lead to breakthroughs in combating cancer drug resistances

New research has revealed the differences in mechanism behind cancer’s resistance to the major class of anti-cancer drugs known as nucleoside analogues.

20 Oct 2021

UVA researchers identify an unknown trigger for epilepsy seizures

Researchers at the University of Virginia School of Medicine have uncovered how problems in cortical microcircuits in the brain can trigger epilepsy seizures.

20 Oct 2021

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

A clinical study by a team of scientists from Norway aimed to assess the immunogenicity and safety of a third dose of COVID-19 mRNA vaccine in MS patients treated with anti-CD20 therapy or fingolimod. A preprint version of the study, which is yet to undergo peer review, is available on the medRxiv* server.

20 Oct 2021

Study reviews various diagnostic models of psychosis

Journal of Psychotherapy and Psychosomatics Standard diagnostic systems, the predominantly categorical DSM-5 and ICD-11, have limitations in validity, utility, and predictive and descriptive power.

20 Oct 2021

Cancer patients opt telemedicine over in-person visits

New research in the October 2021 issue of JNCCN - Journal of the National Comprehensive Cancer Network assessed patient satisfaction and preferences for telemedicine, finding 45% of people with cancer preferred telemedicine, while 34% preferred office visits, and 21% had no preference.

20 Oct 2021

Deep learning algorithm can accurately detect molecular pathways, key mutations in colorectal cancer

A new deep learning algorithm created by researchers from the University of Warwick can pick up the molecular pathways and development of key mutations causing colorectal cancer more accurately than existing methods, meaning patients could benefit from targeted therapies with quicker turnaround times and at a lower cost.

20 Oct 2021

Brain's motor cortex may play a larger role in Parkinson’s disease, study reveals

The role of neuron and dopamine loss in Parkinson's Disease (PD) has long been recognized by neuroscientists.

19 Oct 2021

Infrared light therapy may potentially benefit people with dementia

Infrared light therapy might have the potential to help people living with dementia, according to researchers.

19 Oct 2021

Cancer patients living in low-income and rural areas face an increased risk of suicide

Cancer is an unwelcome blow for anyone, but those diagnosed with cancer who live in low-income and rural areas face an increased risk of suicide compared with those living in high-income and urban areas, according to a study by The University of Texas Health Science Center at Houston.

19 Oct 2021

Research may provide clues to how viral infections contribute to neurodegeneration

Some viral diseases could possibly contribute to neurodegeneration. DZNE researchers report this in the scientific journal "Nature Communications".

19 Oct 2021

Researchers discover new way to jump-start the immune system to attack tumors

Immunotherapy is a promising strategy to treat cancer by stimulating the body's own immune system to destroy tumor cells, but it only works for a handful of cancers.

19 Oct 2021

New AI-based computer algorithm may enable quicker diagnosis of heart failure

A special artificial intelligence (AI)-based computer algorithm created by Mount Sinai researchers was able to learn how to identify subtle changes in electrocardiograms (also known as ECGs or EKGs) to predict whether a patient was experiencing heart failure.

19 Oct 2021

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

A retrospective study led by Northwestern Medicine investigators found that the chimeric antigen receptor (CAR) T-cell immunotherapy drug tisagenlecleucel demonstrated safety and efficacy in pediatric patients with relapsed and refractory B-cell acute lymphoblastic leukemia (B-cell ALL), even when the drug doesn't meet the FDA's strict manufacturing standards.

19 Oct 2021

Medical Condition News

Personalized clotting profiles could benefit people at risk from strokes and heart attacks

Discovery could lead to new treatments for axial spondyloarthritis

Albert Einstein College of Medicine wins new NIH funding to support diabetes research

Discovery could help develop a new treatment strategy for patients with melanoma

Study investigates whether continued magnetic seizure therapy can prevent relapse of depression

Underexpression of specific metabolic enzyme is a common feature in kidney cancer, study shows

U-M study receives $13 million grant to track cancer risk from environmental exposures

Research may lead to breakthroughs in combating cancer drug resistances

UVA researchers identify an unknown trigger for epilepsy seizures

An investigation of three SARS-CoV-2 mRNA doses in multiple sclerosis vaccine non-responders

Study reviews various diagnostic models of psychosis

Cancer patients opt telemedicine over in-person visits

Deep learning algorithm can accurately detect molecular pathways, key mutations in colorectal cancer

Brain's motor cortex may play a larger role in Parkinson’s disease, study reveals

Infrared light therapy may potentially benefit people with dementia

Cancer patients living in low-income and rural areas face an increased risk of suicide

Research may provide clues to how viral infections contribute to neurodegeneration

Researchers discover new way to jump-start the immune system to attack tumors

New AI-based computer algorithm may enable quicker diagnosis of heart failure

New findings may help widen therapeutic interventions for B-cell acute lymphoblastic leukemia

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News